Corcept Therapeutics | GJELD



Debt Endring Dato
Acadia Pharmaceuticals USD 0 0 2024-12
Alaunos Therapeutics USD 0 0 2024-09
ANI Pharmaceuticals USD 624.09M 304.02M 2024-12
Ardelyx USD 150.85M 50.15M 2024-12
Aurora Cannabis CAD 100.98M 11K 2024-12
BioMarin Pharmaceutical USD 596.24M 1.61M 2024-12
Bristol-Myers Squibb USD 49.65B 103M 2024-12
Canopy Growth CAD 489.67M 123.85M 2024-12
Corcept Therapeutics USD 0 0 2024-12
Eli Lilly USD 33.64B 2.52B 2024-12
J&J USD 36.63B 883M 2024-12
Knight Therapeutics CAD 58.22M 109K 2024-09
Merck USD 37.11B 1.02B 2024-12
Novartis USD 31.26B 828M 2024-12
Novartis USD 31.26B 828M 2024-12
Pacira USD 585.32M 2.04M 2024-12
Pfizer USD 64.35B 3.35B 2024-12
Supernus Pharmaceuticals USD 0 0 2024-12
TG Therapeutics USD 244.43M 271K 2024-12



Corcept Therapeutics GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.